Purpose: As cone-beam CT (CBCT) systems dedicated to various imaging specialties proliferate, technical assessment grounded in imaging physics is important to ensuring that image quality and radiation dose are quantified, understood, and justified. This paper involves technical assessment of a new CBCT scanner (CS 9300, Carestream Health, Rochester, NY) dedicated to imaging of the ear and sinuses for applications in otolaryngology-head and neck surgery (OHNS). The results guided evaluation of technique protocols to minimize radiation dose in a manner sufficient for OHNS imaging tasks.
I. INTRODUCTION
X-ray computed tomography (CT) has proliferated over the last several decades as an important medical imaging modality with widespread application in diagnosis, surgical guidance, and monitoring. Chief among the considerations in applying this prevalent modality are radiation dose and imaging performance. As multidetector CT (MDCT) continues to grow and benefit from appropriate utilization criteria, low-dose scan protocols, iterative reconstruction techniques, multienergy capabilities, and new applications, a variety of application-specific embodiments of cone-beam CT (CBCT) have emerged over the last decade. Most current embodiments of CBCT employ variations of the Feldkamp-Davis-Kress (FDK) algorithm 1 for 3D filtered backprojection, although CBCT will similarly benefit from advances in iterative reconstruction techniques and low-dose protocols. 2 The scope of application-specific CBCT embodiments include dental/maxillofacial imaging, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] temporal bone imaging, [14] [15] [16] breast imaging, 17 musculoskeletal imaging, 18 image-guided radiotherapy, 19, 20 and image-guided surgery. 21, 22 Each offers the potential for nearly isotropic, submillimeter spatial resolution combined with soft-tissue contrast resolution approaching that of MDCT (but typically limited by factors such as x-ray scatter, limited field of view (FOV), and increased noise).
The proliferation of these new applications of CBCTeach involving new system geometries, scan orbits, radiation dose profiles, and image quality characteristics-heightens the need for quantitative technical assessment grounded in scientific methodology and imaging physics to rigorously quantify the performance of such systems, ensure that they are appropriately deployed, understand their performance capabilities with respect to specific imaging tasks, and guide knowledgeable selection of technique protocols. This paper concerns the technical assessment of a new CBCT system (CS 9300, Carestream Health, Rochester, NY) developed specifically for otolaryngology-head and neck surgery (OHNS) and maxillofacial imaging [alternatively -ear, nose, and throat (ENT) imaging]. Comparable systems now commercially available in a range of dental/ENT applications include the MiniCAT (Xoran, Ann Arbor, MI), CB Mercuray (Hitachi, Twinsburg, OH), NewTom (QR, Verona, Italy), i-CAT (Imaging Sciences, Hatfield, PA), Accuitomo 170 (J. Morita USA, Irvine, CA), and others. The CS 9300 includes modifications of various characteristics in comparison to previous platforms (9000 series) from the same manufacturer, including: options for expanded field of view (FOV); a variety of full scan (360 • ) and short scan (at least 180 • + fan angle) protocols with various FOV and scan speed; pulsed or continuous x-ray source; and enhanced acquisition and reconstruction software.
The technical assessment reported below addresses the dosimetric properties and image quality associated with manufacturer-specified technique protocols of the CS 9300 for OHNS imaging. Results are compared to reports in the scientific literature, but a head-to-head comparison of performance versus other CBCT (or MDCT) systems 15, 23, 24 is beyond the objectives of the current work. Rather, the work reported below focuses on a system-specific technical assessment that was performed, first, to guide knowledgeable selection of minimum-dose protocols sufficient for relevant imaging tasks prior to deployment in clinical studies at our institution, and second, as a basis of performance comparison with other systems reported in the literature.
II. METHODS AND MATERIALS

II.A. The CS 9300 and default protocols
According to the manufacturer, the intended use of the CS 9300 scanner is ". . . to produce 3D digital x-ray images of the dento-maxillo-facial and ENT regions as diagnostic support for pediatric and adult patients." The scanner capabilities and specifications are summarized in Table I . The default imaging protocols deployed on the system are summarized in Table II , including three sinus protocols (denoted S) and four ear (temporal bone) protocols (denoted E). All measurements involving the unilateral temporal bone protocols (E2, E3, and E4) were performed with the right ear protocol. The left ear protocols were spot-checked to be symmetric with respect to the contralateral side. The angular extent, FOV, and number of projections are all nonmodifiable parameters for each imaging protocol, but the kVp and mAs may be freely adjusted at the discretion of the technologist. The "short-scan" orbits are comparable to half-scan orbits (180
• + fan), with orbital extent particular to each protocol detailed separately below and in Table II. An initial technical assessment was performed (data not shown) that motivated modifications to the scan orbits (start and stop angles of the x-ray source and detector) and the technique chart (reduction in kVp and mAs). Results presented below pertain to protocols and measurements after such modifications unless specifically noted. The resulting protocols (detailed below) reduced dose by up to 30% and better situated the short-scan orbits to impart dose preferentially to the posterior of the head (and reduce anterior dose -e.g., to the eyes). 
II.B. Dose measurement: Experimental setup
Dose measurements were performed with methodology adapted from those outlined in AAPM Task Group Report No. 111. 25 As shown in Fig. 1 , three acrylic cylindrical phantoms of 16 cm diameter (CTDI phantoms) were stacked along the central longitudinal axis to simulate the "head," and a 0.6 cm 3 Farmer ionization chamber was used in conjunction with a Radcal electrometer (AccuDose, Radcal Corp., Monrovia, CA) to measure the central and peripheral doses imparted for all protocols listed in Table III ments used up-to-date manufacturer calibration of the electrometer and accounted for temperature-pressure corrections at the time of measurement. Measurements were nominally performed at the level of the central axial slice of the image volume. A further measurement of dose as a function of kVp and mAs was performed for the S1 protocol and the E1 , where A = anterior, P = posterior, R = Right, and L = left. The protocols are in Table II . The measurement locations are shown in Fig. 2 . protocol. The central dose (D o ) was defined as the absolute dose (mGy) at the center of the CTDI phantom for each scan for each protocol. Peripheral dose was measured at four cardinal locations at the periphery of the CTDI phantom (at the same level as the central dose), with all other experimental factors held constant. Since several of the protocols involved short-scan orbits of the source and detector about the head, the peripheral dose varied at each of the measurement points (e.g., highest at the posterior point for short-scan orbits in which the source traverses the posterior of the head). In addition to the central absolute dose (D o ) the four peripheral dose measurements (D periph ) were averaged to yield a "weighted" dose value analogous to CTDI w , specifically:
where L and W refer to the length and width of the image FOV. Similarly, the dose-length product was DLP = D W · L. To the limited extent that is meaningful to convert the absolute dose from such orbits to the "effective dose" (D E , mSv) and to permit comparison to other systems for which results have been reported only in terms of effective dose (mSv), we used the tissue conversion factor for the head (k Head = 0.0023 mSv/mGy/cm) given by ICRP Publication 103 26 and computed D E = k Head · DLP. The limitation and approximation of this approach is recognized-namely, that effective dose conversion for short-scan orbits is not strictly defined. Specifically, the required tissue conversion factors were developed in the context of conversion from CTDI w . The short-scan measurements of absolute dose (mGy) are valid, but the effective dose values (mSv) should be recognized as approximate and are only included for comparison with other systems that only report mSv.
Dose distribution "maps" were generated using a smoothed interpolation of the five measurement points (the central dose and four peripheral doses) for each protocol. The dose maps provide visualization of heterogeneous dose distribution about the lateral, posterior, and anterior aspects of the head, particularly for the various short-scan protocols. They do not pretend to account for tissue heterogeneities, though they are a valuable means of conveying dose distributions to the clinicians and manufacturer with respect to the various scan orbit pathways.
A further study was conducted with S1 and E1 protocols to characterize the out-of-field dose [D o (z)] along the longitudinal axis. The absolute dose to the center of the CTDI phantom was measured as a function of z (longitudinal position) beginning at the central plane, covering the extent of the primary collimated x-ray field, and extending inferiorly beyond the field toward the "neck." The same experimental setup of three stacked CTDI phantoms was used for this assessment, with the ionization chamber position manually translated along the z axis in ∼2 cm increments.
II.C. Imaging performance
Performance measurements used two CatPhan modules (CTP404 and CTP528) and a custom SolidWater TM cylinder with tissue-simulating plastic inserts (Gammex RMI, Madison, WI). The signal difference to noise ratio (SDNR) was calculated as follows:
whereμ insert is the average voxel intensity of a specified insert,μ background is the average voxel intensity of the background material adjacent to (and at the same radius as) the insert, and σ insert and σ background are the standard deviations in the respective regions.
II.C.1. High-contrast SDNR
The CTP404 insert containing various plastic cylindrical inserts was used to assess high-contrast SDNR. For all protocols, the SDNR was calculated between polystyrene (measured 91 HU) and background (measured −26 HU). The dose-normalized SDNR was computed by dividing by the square root of the measured absolute dose (D o ) for each protocol. Due to the presence of a significant blush and ring artifact and lateral truncation artifacts (depending on FOV), the region of interest (ROI) location for calculation of SDNR was selected to avoid such artifacts while maintaining equal radius from the center of the image for all inserts and background ROIs.
II.C.2. Low-contrast (Soft-tissue) SDNR
Further study of the low-contrast resolution capabilities of the scanner was performed using a SolidWater phantom with inserts that simulated soft-tissue densities. Tissueequivalent inserts (Gammex RMI, Madison, WI) included adipose (−112 HU), solid water (0 HU), brain (6 HU), and liver (87 HU). Soft-tissue SDNR was calculated in the same manner as described above.
II.C.3. HU accuracy
The same phantoms were scanned with a MDCT scanner (Somatom Definition Flash, Siemens Healthcare, Forcheim, Germany) using standard clinical "head" protocols (120 kVp, 125 mAs, T80f kernel, 0.4 × 0.4 × 0.4 mm 3 voxel size), and the HU values reported by the MDCT scanner and CS 9300 scanner were compared.
II.C.4. Spatial resolution
Spatial resolution was assessed qualitatively using a linepair phantom (CTP528 module of the CatPhan) for all protocols. Quantitative assessment of spatial resolution for the S1 and E1 protocols was performed by measurement of the modulation transfer function (MTF) from a wire phantom. The MTF was calculated as the Fourier transform of an oversampled line-spread function (LSF) derived from Radon transform of axial images of the wire within a cylindrical phantom under tension, slightly angled to the longitudinal image axis. Radon transform, oversampling, LSF normalization, and MTF estimation followed similar procedures as previously published works. 27, 28 
II.C.5. Image quality in an anthropomorphic head phantom
An overall qualitative assessment of image quality was performed using scans of an anthropomorphic RANDO head phantom (natural human skeleton in tissue-equivalent plastic; The Phantom Laboratory, Greenwich, NY). Images were qualitatively assessed by a rhinologist and an otologist with respect to the visibility of pertinent anatomical structures and overall diagnostic quality. The potential for more quantitative observer performance assessment is recognized (e.g., ROC tests), but is beyond the scope of the technical assessment reported here. The qualitative interpretation by expert clinicians was valuable, complementary, and confirmatory of measurements of SDNR and MTF.
III. RESULTS
The results detailed below correspond to a second technical assessment of the CS 9300 after modifications were made based upon recommendations arising from an initial technical assessment performed using the same methods and experimental setup. A summary of results from the initial assessment for purposes of comparison is as follows. The initial sinus protocols (S1, S2, and S3) employed a 90 kVp beam (5 kVp greater than those listed in Table II) Table II ). The ear protocols (E1, E2, E3, and E4) did not change in beam energy, but the mA was reduced from 6.3 mA to 5 mA for E1 and from 8 mA to 6.3 mA for E2, E3, and E4. Several of the source-detector orbits in the initial protocols were also modified to those illustrated in Fig. 2 : The S2 protocol, for example, initially involved a longer arc beginning at the right ear, traversing the posterior of the head, and ending anterior to the left ear; similarly, the E1 protocol involved an arc beginning posterior to the right ear, traversing the posterior of the head and ending at the left anterior of the head; other scan trajectories were as shown in Fig. 2 . The adjustment of the S2 and E1 protocols to those shown in Fig. 2 
III.A. Dose
Dose measurements demonstrated that all protocols deployed on the CS 9300 scanner are similar to (or somewhat lower than) those reported for comparable CBCT scanners as well as those reported for MDCT head protocols. Table III summarizes the dose measurements, where central dose is seen to be in the range 2.9-5.7 mGy, depending on the specific protocol. For example, the lowest and highest dose protocols (E3 and S1, respectively) gave D o = 2.9 and 5.7 mGy, D w = 3.7 and 6.0 mGy, DLP = 18 and 81 mGy cm, DAP = 92 and 1370 mGy cm 2 , and D E = 0.04 and 0.19 mSv, respectively. By comparison, Ludlow et al. 23 reported doses for comparable scanners to be between 0.05 mSv (NewTom) and 1 mSv (Mercury). Because other reports in the literature utilized thermoluminescent dosemeters (TLDs) and were aimed at patient dose characterization instead of absolute dose ("output") of the scanner itself, a comparison in terms of absolute dose (mGy) is not available. In comparison to MDCT of the head, the median value for CTDI W reported by Pantos et al. 29 was approximately 52 mGy, with a range of 17-181 mGy measured over 17 studies spanning approximately two decades. The measured value of D W (the approximate analog of CTDI W for short-scan orbits) for the CS 9300 is considerably lower than the lowest CTDI W reported for MDCT, although ongoing advances in dose reduction and improved reconstruction algorithms will likely drive MDCT to still lower values. Some of those same advances will likely apply to further dose reduction in CBCT as well. Table I . The top left image "Key" shows the legend for: tube start angle, tube stop angle, center of rotation, and center of the object. The small FOV for the unilateral scan protocols are shown as dotted circles in E2, E3, and E4.
As shown in Fig. 2 , the various scan orbits impart very different dose distributions: for a 360
• orbit (S1), the dose deposition is the expected, radially symmetric dose distribution with exponential attenuation toward the center of the phantom; for the short-scan and unilateral orbits, however, the dose is deposited predominantly at the posterior of the head (S2, S3, and E1) and/or unilaterally (E2, E3, and E4). These differences in scan orbit yield variation in the peripheral dose that in turn affects the "weighted" and "effective" dose shown in Table III . The dose maps in Fig. 2 further demonstrate that the short-scan orbits achieve considerable dose sparing of the anterior region, including the eyes. Some implications with respect to dosimetry standards and further improvements in anterior dose sparing are discussed below. view. The falloff was anticipated to be fairly gradual due to scatter in the broad volumetric beam. The longitudinal dose tails fall to ∼10% of the maximum central dose at ∼8 cm from the edge of the FOV and to ∼1% of the maximum central dose at ∼12 cm from the edge of the FOV. Assuming an approximate thyroid position at ∼8 cm below the chin, the dose to the thryoid would be approximately 1.1 mGy and 0.8 mGy for the S1 and E1 protocols, respectively. Previous work 30 shows that a majority of the out-of-field dose arises from internal scatter through the patient, and a thyroid shield would not be effective in limiting dose to thyroid, since x-ray scatter originates in the head and travels "down" the neck.
III.B. Signal difference to noise ratio and CT number accuracy
The SDNR was measured for all sinus and temporal bone protocols as summarized in Fig. 4 . Overall, the temporal bone protocols provided slightly improved SDNR in comparison to the sinus protocols, attributed primarily to the smaller FOV and beam width, resulting in reduced x-ray scatter. The images also illustrate the variation in FOV size and placement (shifts of the gantry as noted in Fig. 2 ): S1 covers the entire phantom; S2 and S3 shift the FOV anteriorly (to cover the sinuses); E1 is intended to cover the bilateral posterior aspect of the head (temporal bones); and E2, E3, and E4 place a smaller FOV unilaterally (L or R temporal bone). For the results in Fig. 4 , the phantom was not moved in cases S1, S2, S3, and E1, but was rotated in cases E2, E3, and E4 such that the polystyrene insert (indicated by the arrow in Fig. 4(a) ) remained in the FOV for purposes of comparison and SDNR analysis.
The low-contrast imaging performance was investigated further for the S1 and E1 protocols to assess the potential for soft-tissue visualization (beyond the fairly high-contrast inserts of the CatPhan modules). Images of the 16 cm SolidWater phantom with various tissue-equivalent inserts are shown in Fig. 5 . Soft-tissue inserts include (W) solid water, (L) Figure 6 shows the voxel values reported by the CS 9300 plotted versus the HU reported by the MDCT scanner (standard head protocol at 120 kVp, Siemens Somatom Definition Flash). Note that the manufacturer does not claim accurate HU calibration on the CS 9300. A fairly linear relationship is observed, related by slopes of 0.7 and 0.8 for the S1 and E1 protocols, respectively. A slope less than 1.0 is presumably associated with increased x-ray scatter (larger cone angle) for the CS 9300, which appears to dominate over HU discrepancies associated with the lower kVp. The lower slope for the S1 protocol compared to the E1 protocol is similarly consistent with increased x-ray scatter associated with the larger FOV. This level of HU inaccuracy is typical for CBCT systems and present an area for further improvement through careful calibration procedures. 31, 32 
III.C. Spatial resolution
As shown in Fig. 7 , all protocols exhibited spatial resolution better than 10 lp/cm in a qualitative assessment of the line-pair phantom. The unilateral temporal bone protocols (E2, E3, and E4) demonstrated the highest spatial resolution, ∼13 lp/cm. The differences observed in the limiting spatial resolution among various protocols are attributed to the technique parameters shown in Table II , most notably voxel size. Specifically, S1 and S3 (each with voxel size 0.3 mm) have superior spatial resolution compared to S2 (voxel size 0.5 mm). The difference in spatial resolution between S1 and S3 is more subtle and can be attributed to superior view sampling for the latter -the number of views are approximately equal for both protocols, but they are spread over a larger angle for S1 than for S3.
More quantitative assessment of spatial resolution is shown in the MTF measurements of Fig. 8 , where the S1 and E1 protocols were found to give MTF exceeding 10% out to 20 lp/cm or more. The MTF is slightly improved for the E1 protocol, owing to the smaller FOV (reduced x-ray scatter and finer voxel sampling). The system interface in its current implementation does not allow adjustment of the reconstruction filter ("kernel"), and the filters associated with each protocol are not reported. It is not known if the filter varies between protocols.
III.D. Image quality assessed in an anthropomorphic Rando phantom
Images of the anthropomorphic head phantom in Figs. 9 and 10 provided qualitative assessment of the various scan protocols with respect to pertinent clinical tasks in sinus and otology imaging. As illustrated in Fig. 9 , the three sinus protocols were each assessed as generally acceptable with respect to high-contrast visualization of the frontal, ethmoid, maxillary, and sphenoid air cells, lamina papyracea, and skull base (including the carotid canals, vidian canal, and pituitary bulb). Based on qualitative assessment of sinus feature visibility combined with the quantitative assessment of dose, contrast resolution, and spatial resolution detailed above, the S3 protocol was identified as the preferred default (adult) protocol for sinus imaging. The S2 protocol was identified as an alternative, lower-dose protocol to be used in situations where spatial resolution requirements were reduced, soft-tissue requirements were increased, and/or there was heightened sensitivity to radiation dose (e.g., pediatric or repeat longitudinal imaging).
As illustrated in Fig. 9 , axial, coronal, and sagittal views of the sinuses demonstrated resolution of fine anatomic details and air-bone interfaces. Figure 10 demonstrates the image quality for all four temporal bone protocols, which were each considered acceptable for visualization of mastoid air cells, semicircular canals, and cochlea. Isotropic 3D spatial resolution was identified as a significant strength, comparable to high-resolution temporal bone protocols in MDCT and suitable for excellent visualization of submillimeter structures at air-bone interfaces-for example, semicircular canal dehiscence. Utility in soft-tissue visualization (e.g., cholesteatoma) was difficult to assess but (based on qualitative comparison in the same phantom) was likely inferior to MDCT. Image quality in the presence of metal (e.g., cochlear implant) was not assessed in the current work. Overall, the bilateral E1 protocol was considered generally most useful, allowing assessment of both temporal bones from a single scan and facilitating visualization of left-right symmetry. The unilateral protocols (E2, E3, and E4) require careful patient positioning and FOV placement to avoid truncation of structures of interest, and the scan orbits illustrated in Fig. 2 were considered dosimetrically disadvantageous compared to E1 with respect to dose to the anterior head. The E2 protocol was identified as a potential alternative in situations demanding increased spatial resolution in which a unilateral view was sufficient, but requires careful attention on the part of the technologist to assure that the region of interest is within the smaller FOV.
IV. DISCUSSION AND CONCLUSIONS
A new commercially available CBCT scanner (CS 9300) for application in OHNS imaging (including maxillofacial, ENT, and otology imaging) was assessed in terms of technical performance (dose, contrast resolution, and spatial resolution) and applicability in a spectrum of clinical imaging tasks (qualitative assessment of anatomical visibility in the sinuses and temporal bones). The CS 9300 was found to provide comparable or somewhat improved radiation dose characteristics compared to those reported for similar applicationspecific CBCT scanners 23 as in the studies performed by Ludlow et al. for other devices. While direct comparison to conventional (whole-body) MDCT systems is not within the scope of the current work, general considerations of spatial resolution, radiation dose, cost, and site logistics (hospital versus office-based) suggest relative merits of specialized CBCT and MDCT systems. Qualitatively, the results suggest that CBCT offers reduced radiation dose and comparable or somewhat superior spatial resolution in comparison to common MDCT protocols, but soft-tissue contrast resolution is reduced. Cost and site requirements are likely advantageous to the simpler, application-specific CBCT systems.
Image quality was judged satisfactory for high-contrast visualization tasks in sinus and temporal bone imaging, with isotropic spatial resolution identified as a significant strength. Soft-tissue contrast resolution was somewhat limited in the current implementation. The scanner included a number of application-specific scan protocols, with the S2 and E1 protocols judged to be most generally useful in terms of clinical utility, satisfaction of image quality requirements, and respectful of the desire for low-dose acquisition techniques.
A number of observations and recommendations can be appreciated in considering the dose maps of Fig. 2 . The first is the obvious challenge posed by short-scan orbits to conventional dosimetry standards: in addition to the limitations in CTDI noted by Dixon et al. 33 is the fact that the central dose, D o , alone does not differentiate between protocols that better spare the anterior of the head (e.g., S2 versus E4, each with D o ∼3.3 mGy, but differing in anterior dose by a factor of 4). A simple variation on the "weighted" D w was suggested to incorporate the average peripheral dose as a somewhat more useful approximation for short-scan techniques. As currently implemented by the manufacturer, the unilateral protocols (E2, E3, and E4) shift the scan orbit off-center and laterally. For imaging of the right ear (which was the case for all unilateral cases in this work), the scanner shifts laterally to the left, thereby depositing the highest dose outside the FOV. We hypothesized that an improvement in quantum noise and sampling characteristics would be achieved by shifting instead to the right (not the left), placing the FOV on the region receiving a higher dose (reduced quantum noise) with higher density of backprojected rays (for a short-scan orbit). We also noted that all of the short-scan orbits (specifically, E2, E3, and E4) could be better constrained as in S2, S3, and E1 such that the x-ray tube passes posterior to the head in order to spare anterior dose. These recommendations were relayed to the manufacturer to be considered in future implementations. There was no capability for mA modulation in the current implementation, although this might allow further dose reduction if properly implemented.
The technical assessment performed above was performed preliminary to a patient trial to be conducted at our institution. All of the results reported above were based on a second technical assessment -the first assessment highlighting a number of potential improvements that were constructively incorporated by the manufacturer. The main recommendations highlighted in the first assessment were: (1) a reduction in kVp for each protocol by 5-10 kVp to the values shown in Table II; (2) a reduction in mAs by ∼10%-30% to the values shown in Table II ; and (3) an adjustment of the short-scan orbits such that the x-ray tube traverses the posterior of the head in the short-scan orbits (as shown in Fig. 2 for S2, S3, and E1) and not the lateral aspect of the head (which imparted a significantly higher anterior dose). The first and second recommendations were based on quantitative assessment of dose and SDNR, recognizing that the system was primarily providing visualization of high-contrast structures (moreso than soft-tissue) and that task performance could be maintained even at the reduced dose levels. The third recommendation (posterior short-scan orbits) was adopted for the S2, S3, and E1 protocols as shown in Fig. 2 , and incorporation in all cases is being considered by the manufacturer in future implementations. These modifications preliminary to a clinical trial demonstrate the value of rigorous technical assessment in improving the translation of technologies to clinical use.
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